Literature DB >> 26137020

Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.

Satoshi Ikeda1, Keishi Naruse2, Chigusa Nagata1, Masami Kuramochi3, Takuya Onuki3, Masaharu Inagaki3, Keiko Suzuki1.   

Abstract

The present study aimed to examine the effectiveness of immunostaining of cytological specimens in discerning squamous from non-squamous cell carcinoma. Various combinations of six antibodies were examined in order to determine the optimal combination for use in differential diagnosis. Immunostaining was performed using tumor imprint smears obtained from 70 lung carcinoma cases. The results were scored based on positive area and intensity. For objective evaluation, scores for thyroid transcription factor 1 (TTF-1), napsin A, and CK CAM5.2 were expressed with positive values, while those for p40, cytokeratin (CK) 5/6 and CK5 were expressed with negative values. Histograms were produced to evaluate which combination was the most effective in differentiating squamous cell carcinoma from adenocarcinoma. The sensitivity for these molecules in adenocarcinoma was 88% for TTF-1, 85% for napsin A, and 100% for CAM5.2. In squamous cell carcinomas, sensitivity was determined to be 90% for p40, 86% for CK5, and 76% for CK5/6. The specificity for these molecules was calculated as 100%, 95%, 43%, 98%, 100% and 95%, respectively. Each combination was evaluated for scoring and the values were averaged. The most effective combination for mode and mean was TTF-1, napsin A, p40, and CK5, for which all adenocarcinomas had a score >1, and all squamous cell carcinomas scored <-2. Immunostaining scoring may therefore be useful for the differential diagnosis of these carcinomas when a limited number of tumor cells are present.

Entities:  

Keywords:  immunocytochemistry; lung cytopathology; scoring

Year:  2015        PMID: 26137020      PMCID: PMC4467219          DOI: 10.3892/ol.2015.3045

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

2.  Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung.

Authors:  Emmy Yanagita; Naoko Imagawa; Chiho Ohbayashi; Tomoo Itoh
Journal:  Appl Immunohistochem Mol Morphol       Date:  2011-12

3.  Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.

Authors:  Emiko Aikawa; Akihiko Kawahara; Satoshi Hattori; Tomohiko Yamaguchi; Hideyuki Abe; Tomoki Taira; Koichi Azuma; Masayoshi Kage
Journal:  Cancer Cytopathol       Date:  2011-06-29       Impact factor: 5.284

4.  TTF-1 expression in pulmonary adenocarcinomas.

Authors:  Yasushi Yatabe; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Am J Surg Pathol       Date:  2002-06       Impact factor: 6.394

5.  Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.

Authors:  W K Ng; Janson C Y Chow; Peter K H Ng
Journal:  Cancer       Date:  2002-02-25       Impact factor: 6.860

6.  CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma.

Authors:  Rohit Bhargava; Sushil Beriwal; Kim McManus; David J Dabbs
Journal:  Am J Clin Pathol       Date:  2008-11       Impact factor: 2.493

7.  The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.

Authors:  M Uke; B Rekhi; D Ajit; N A Jambhekar
Journal:  Cytopathology       Date:  2009-09-09       Impact factor: 2.073

8.  Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry.

Authors:  Yan Li; Xiangchun Wang; Minghui Ao; Edward Gabrielson; Frederic Askin; Hui Zhang; Qing Kay Li
Journal:  Clin Proteomics       Date:  2013-11-01       Impact factor: 3.988

9.  Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A.

Authors:  T Hirano; G Auer; M Maeda; Y Hagiwara; S Okada; T Ohira; K Okuzawa; K Fujioka; B Franzén; N Hibi; T Seito; Y Ebihara; H Kato
Journal:  Jpn J Cancer Res       Date:  2000-10

10.  Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.

Authors:  Seema Sethi; Lili Geng; Vinod B Shidham; Pamela Archuletta; Sudeshna Bandyophadhyay; Jining Feng; Shashi Madan; Dongping Shi; Paul Tranchida; Tamar Giorgadze
Journal:  Cytojournal       Date:  2012-03-31       Impact factor: 2.091

View more
  4 in total

1.  REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression.

Authors:  Si Sun; Zhihuang Hu; Shenglin Huang; Xun Ye; Jialei Wang; Jianhua Chang; Xianghua Wu; Qifeng Wang; Lanlin Zhang; Xingjiang Hu; Hui Yu
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-19       Impact factor: 4.553

2.  Advanced lung adenocarcinomas with ROS1-rearrangement frequently show hepatoid cell.

Authors:  Jing Zhao; Jing Zheng; Mei Kong; Jianya Zhou; Wei Ding; Jianying Zhou
Journal:  Oncotarget       Date:  2016-11-08

3.  Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics.

Authors:  Kajsa Ericson Lindquist; Inga Gudinaviciene; Nektaria Mylona; Rodrigo Urdar; Maria Lianou; Eva Darai-Ramqvist; Felix Haglund; Mátyás Béndek; Erika Bardoczi; Katalin Dobra; Hans Brunnström
Journal:  Biomolecules       Date:  2021-11-18

4.  The role of Thyroid Transcription Factor-1 and Tumor differentiation in Resected Lung Adenocarcinoma.

Authors:  Tsai-Wang Huang; Ke- Feng Lin; Chien-Hsing Lee; Hung Chang; Shih-Chun Lee; Yi-Shing Shieh
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.